Annual report pursuant to Section 13 and 15(d)

Condensed Financial Statements (Details)

v3.10.0.1
Condensed Financial Statements (Details) - USD ($)
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Nov. 30, 2016
Secured convertible debentures, net of deferred financing costs   $ 892,176  
Total Liabilities $ 2,500,048 1,865,734  
Accumulated deficit (33,252,338) (31,098,864)  
Total Stockholders' Deficiency 157,037 326,623 $ (993,592)
Foreign currency translation (gain) 46,093 (55,007)  
Selling, general and administration 2,125,896 1,919,789  
Total Operating Expenses 2,102,861 2,020,173  
Loss from Operations (2,038,702) (1,918,985)  
Change in fair value of derivative liabilities (Note 14) 188,543 (239,802)  
Accretion 154,428 103,034  
Other expense-Interest 148,887 538,430  
Loss before Income Taxes (2,153,474) (2,800,251)  
Net loss for the period (2,153,474) (2,800,251)  
Comprehensive Loss $ (2,155,147) $ (2,775,517)  
Loss per share - basic and diluted (in dollars per share) $ (0.02) $ (0.05)  
Foreign currency translation (gain) loss $ 46,093 $ (55,007)  
Net cash used in operating activities $ (1,596,120) $ (1,471,031)